Human Urokinase (uPA) ELISA Kit

$407.00

Catalog Number: EU1001-1

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Catalog Number. EU1001-1 Categories: , , Tag: Brand:

Additional information

Format

Sandwich ELISA

Entrez Gene

5328

Components

Biotinylated Human uPA Antibody, Chromogen Substrate (1x), Human uPA Microplate, Human uPA Standard, MIX Diluent Concentrate (10x), Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

4 hours

Sensitivity

45 pg/ml

Range

0.125 – 4 ng/ml

Samples Type

Cell Culture Supernatants, Cell Lysates, Milk, Plasma, Serum, Tissue Extract, Urine

Associated Disease

Cancer

Species

Human

UniProt

P00749

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications citing Assaypro: Human Urokinase (uPA) ELISA Kit... (66 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-?B p65 transcription factor and binding to the uPA promoter, leading

The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line

The influence of opioid peptides on matrix metalloproteinase-9 and urokinase plasminogen activator expression in three cancer cell lines

Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells

Anticancer Activity of New Synthetic ?-Methylene-?-Lactones on Two Breast Cancer Cell Lines

Some Pyrazole and Pyrazolo[3,4-d]pyrimidine Derivatives: Synthesis and Anticancer Evaluation

Comparison of Anti-Invasive Activity of Parthenolide and 3-Isopropyl-2-Methyl-4-Methyleneisoxazolidin-5-One (MZ-6)A New Compound with ?-Methylene-?

Tetrahydroindolocarbazoles (THICZs) as new class of urokinase (uPA) inhibitors: Synthesis, anticancer evaluation, DNA-damage determination, and molecular

Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type

Schwann Cells Promote Tumor Cell Invasion Through Regulation of the Laminin Receptor 61

Schwann Cells Promote Tumor Cell Invasion Through Regulation of the Laminin Receptor ?6?1

Synthesis, characterization and anticancer activity of some transition metal complexes of new Schiff base triazole derivatives

Aggregated low density lipoprotein induce impairment of the cytoskeleton dynamics through UPA/UPAR in human VSMC

SYNTHESIS AND CHARACTERIZATION OF SOME METAL COMPLEXES WITH A LIGAND DERIVED FROM NOVEL 1, 2, 3-TRIAZOLE DERIVATIVE AND

Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative

Low density lipoproteins, vascular smooth muscle cell function and vascular remodeling

Diseo de una herramienta auxiliar en el diagnstico de cncer de pulmn mediante la cuantificacin de protenas biomarcadoras utilizando redes neuronales

Synthesis and anticancer evaluation of some fused pyrazolopyrimidines and their S-acyclic nucleosides

Production, characterization and anticancer activity of Candida bombicola sophorolipids by means of solid state fermentation of sunflower oil cake and soybean oil

Fermented Pomegranate (Punica granatum) Peel Extract as a Novel Anticancer Agent Targeting Angiogenesis and Metastasis

2-{[3-Cyano-4-(furan-2-yl)-6-(naphthalen-1-yl)pyridin-2-yl]oxy}acetohydrazide as a synthon for Potent Anticancer Agents

Anticancer Activity of New Synthetic alpha-Methylene-delta-Lactones on Two Breast Cancer Cell Lines

Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels

The interaction of Leptospira interrogans with juman proteolytic system enhaces dissemination through endothelial cells and the levels of plasminogen activators and matrix metalloprotease-9

Synthesis and docking studies of novel antitumor benzimidazoles

PLASMATIC SIL 6R/IL-6 RATIO AS A POTENTIAL PREDICTOR OF HIGH GLEASON SUM AT RADICAL PROSTATECTOMY

Nafamostat Mesilate (FUT-175) Inhibits Cell Growth and Invasion of Malignant Pleural Mesothelioma Cell Line, MSTO-211H

An oncogenic role of eIF3e/INT6 in human breast cancer

Effects of rhG-CSF Plus Dexamethasone on Hemostatic Parameters in Healthy Granulocyte Donors: Role of u-PA and Nitric Oxide

Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction

Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP)

Effect of hepatocyte growth factor on invasion of prostate cancer cell lines

Tetrahydroindolocarbazoles (THICZs) as new class of urokinase (uPA) inhibitors: Synthesis, anticancer evaluation, DNA-damage determination, and molecular modelling study.

The Effect of Levonorgestrel on Fibrinolytic Factors in Human Endometrial Endothelial Cells

MUC1 Protein Induces Urokinase-type Plasminogen Activator (uPA) by Forming a Complex with NF-κB p65 Transcription Factor and Binding to the uPA Promoter, Leading to Enhanced Invasiveness of Cancer Cells

The Role of Serum Soluble Urokinase-Type Plasminogen Activator Receptor in Stable Chronic Obstructive Pulmonary Disease

uPAR, IL-33, and ST2 Values as a Predictor of Subclinical Chorioamnionitis in Preterm Premature Rupture of Membranes

Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative

Anticancer Activity of New Synthetic α-Methylene-δ-Lactones on Two Breast Cancer Cell Lines

Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels

Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.

Excessive Fibrin Deposition in Nasal Polyps Caused by Fibrinolytic Impairment through Reduction of Tissue Plasminogen Activator Expression

Synthesis and docking studies of novel antitumor benzimidazoles

Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance

The influence of opioid peptides on matrix metalloproteinase-9 and urokinase plasminogen activator expression in three cancer cell lines

A novel fibrinogenase from Agkistrodon acutus venom protects against DIC via direct degradation of thrombosis and activation of protein C

Comparison of Anti-Invasive Activity of Parthenolide and 3-Isopropyl-2-Methyl-4-Methyleneisoxazolidin-5-One (MZ-6) - A New Compound with α-Methylene-γ-Lactone Motif - on Two Breast Cancer Cell Lines

Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group

An oncogenic role of eIF3e/INT6 in human breast cancer

First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases

The Influence of Opioids on Urokinase Plasminogen Activator on Protein and mRNA Level in MCF-7 Breast Cancer Cell Line

Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: Preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells

Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal–epidermal junction

Effects of rhG-CSF Plus Dexamethasone on Hemostatic Parameters in Healthy Granulocyte Donors: Role of u-PA and Nitric Oxide

Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells

In vitro regulation of adipogenesis: tunable engineered tissues

Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells

High Concentrations of Plasminogen Activator Inhibitor-1 in Lungs of Preterm Infants With Respiratory Distress Syndrome

Possible Involvement of Urokinase-Type Plasminogen Activator Release From Human Peripheral Blood Lymphocytes in the Pathophysiology of Chronic Allograft Nephropathy

HMG-CoA Reductase Inhibitors Reduce Matrix Metalloproteinase-9 Activity in Human Varicose Veins

Inhibition and Mechanism of Action of a Protease Inhibitor in Human Pancreatic Cancer Cells

Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion

Suppression of the release of type-1 plasminogen activator inhibitor from human vascular endothelial cells by Hawaii deep sea water

Loading data...